Connection
David Hall to Neoplasms
This is a "connection" page, showing publications David Hall has written about Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.216 |
|
|
|
-
Ortendahl JD, Carter GC, Zantema EM, Hoag JR, Starodynov A, White KL, Basu GD, Tharayanil A, De La O JP, Hall DW, Baehner FL. Costs and benefits of whole-exome, whole-transcriptome sequencing versus 50-gene panels for genomic profiling in solid tumors. J Med Econ. 2026 Dec; 29(1):1046-1058.
Score: 0.078
-
De La O JP, Hoag JR, Deem AK, Wang M, Starodynov A, Udhane SS, LoBello JR, Therala N, Hall DW, Basu GD, Baehner FL. Comprehensive genomic profiling of over 10,000 advanced solid tumors. Oncotarget. 2025 07 25; 16:587-603.
Score: 0.074
-
Gibbs SN, Peneva D, Cuyun Carter G, Palomares MR, Thakkar S, Hall DW, Dalglish H, Campos C, Yermilov I. Comprehensive Review on the Clinical Impact of Next-Generation Sequencing Tests for the Management of Advanced Cancer. JCO Precis Oncol. 2023 06; 7:e2200715.
Score: 0.064
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|